U.S., April 19 -- ClinicalTrials.gov registry received information related to the study (NCT06933355) titled 'Acute Effects of SGLT2 Inhibitor on Kidney Allograft Oxygen Tension' on April 01.
Brief Summary: The goal of this clinical trial is to investigate if a single dose of oral SGLT2i, (50 mg Jardiance) will change oxygen tension in the kidney transplant.
The main questions it aims to answer are:
* Does a single dose of oral SGLT2i (50 mg Jardiance) change oxygen tension in the kidney transplant cortex and medulla, estimated by magnetic resonance imaging?
* Does a single dose of oral SGLT2i (50 mg Jardiance) change kidney transplant cortical and medullary perfusion?
* Does a single dose of oral SGLT2i (50 mg Jardiance) change kidney...